A carregar...
Low-dose axitinib rechallenge with positive outcomes in a patient with metastatic renal cell carcinoma refractory to interferon α, sunitinib, axitinib, and nivolumab therapies: a case report
BACKGROUND: There is no established treatment after failure of proven therapies for patients with metastatic renal cell carcinoma. CASE PRESENTATION: A 66-year-old Japanese man with metastatic renal cell carcinoma became refractory to interferon α and sunitinib therapies. He started treatment with a...
Na minha lista:
| Publicado no: | J Med Case Rep |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BioMed Central
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6475964/ https://ncbi.nlm.nih.gov/pubmed/31006385 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13256-019-2041-8 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|